Ashland Inc. will sell its Avoca business to Mane, expected to close by Q1 2025.
Quiver AI Summary
Ashland Inc. announced the signing of a definitive agreement to sell its Avoca business to Mane, with the transaction expected to close in the first quarter of 2025 pending customary closing conditions. The Avoca business, focusing on Sclareolide—a fragrance fixative—and contract manufacturing, is the last remaining part of Ashland's acquisition of Pharmachem. CEO Guillermo Novo praised the Avoca team for their dedication and capabilities. The press release also includes forward-looking statements regarding the sale and Ashland's business outlook, noting that actual results may differ due to various risks.
Potential Positives
- Ashland Inc. has signed a definitive agreement to sell its Avoca business, allowing the company to streamline its operations and focus on core areas, which is typically viewed positively by investors.
- The sale of the Avoca business, which specializes in fragrance fixatives, marks the end of Ashland's previous acquisition of Pharmachem, potentially improving financial clarity and strategic direction for the company moving forward.
- The transaction is expected to close in the first quarter of 2025, indicating a timely resolution to this aspect of Ashland's portfolio management.
Potential Negatives
- The sale of the Avoca business indicates a potential downsizing or strategic shift for Ashland, which could raise concerns among investors about the company's long-term growth prospects.
- The uncertainty associated with the closing conditions of the sale may lead to speculation about operational challenges or risks within the company.
- This transaction marks the divestiture of the last entity from Ashland's previous acquisition of Pharmachem, possibly reflecting poorly on the success of that acquisition strategy.
FAQ
What is the Avoca business being sold by Ashland?
The Avoca business supplies Sclareolide, a fragrance fixative, and contract manufacturing services from facilities in North Carolina and Wisconsin.
Who is acquiring Ashland's Avoca business?
The Avoca business is being sold to Mane, a leading global producer of fragrances and flavours.
When is the expected closing date for the transaction?
The transaction is expected to close in the first quarter of 2025, pending customary closing conditions.
What statement did Ashland's CEO make about the Avoca business?
Guillermo Novo, CEO of Ashland, praised the Avoca business for its dedicated team and strong capabilities in the fragrance fixative market.
Where can I find more information about Ashland's forward-looking statements?
More details on forward-looking statements can be found in Ashland's recent Form 10-K and on their SEC and investor relations websites.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ASH Insider Trading Activity
$ASH insiders have traded $ASH stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ASH stock by insiders over the last 6 months:
- ROBIN E. LAMPKIN (SVP, Gen Counsel and Secrty.) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,030 shares.
- J KEVIN WILLIS (SVP and CFO) sold 5,487 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ASH Hedge Fund Activity
We have seen 148 institutional investors add shares of $ASH stock to their portfolio, and 230 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. added 866,320 shares (+6127.2%) to their portfolio in Q3 2024
- NEUBERGER BERMAN GROUP LLC removed 726,590 shares (-62.8%) from their portfolio in Q3 2024
- EMINENCE CAPITAL, LP removed 506,748 shares (-16.1%) from their portfolio in Q3 2024
- CEREDEX VALUE ADVISORS LLC removed 391,700 shares (-75.7%) from their portfolio in Q3 2024
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 305,693 shares (-100.0%) from their portfolio in Q3 2024
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 284,215 shares (+12.3%) to their portfolio in Q3 2024
- BALYASNY ASSET MANAGEMENT L.P. removed 271,853 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Wilmington, Del., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the calendar first quarter 2025, subject to the satisfaction of customary closing conditions.
Ashland's Avoca business supplies Sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin. The Avoca business line represents the last entity from Ashland’s previous acquisition of Pharmachem.
“The Avoca business is a strong player in the fragrance fixative space with a dedicated team and attractive manufacturing capabilities to meet customer needs,” said Guillermo Novo, chair and chief executive officer, Ashland. “I want to thank the Avoca employees for their dedication and commitment to Ashland and to our customers.”
Squire Patton Boggs is acting as legal advisor to Ashland.
Update Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as “anticipates,” “believes,” “expects,” “estimates,” “is likely,” “predicts,” “projects,” “forecasts,” “objectives,” “may,” “will,” should,” “plans” and “intends” and the negative of these words or other comparable terminology. In addition, Ashland may from time to time make forward-looking statements in its annual report to shareholders, quarterly reports and other filings with the Securities and Exchange Commission (SEC), news releases and other written and oral communications. These forward-looking statements are based on Ashland’s expectations and assumptions, as of the date such statements are made, regarding Ashland’s future operating performance, financial condition, operating cash flow and liquidity, as well as the economy and other future events or circumstances. These statements include, but may not be limited to, statements about the sale of the Avoca business, including the expected timing for closing of the sale. Various risks and uncertainties may cause actual results to differ materially from those stated, projected or implied by any forward-looking statements, including any delay in the satisfaction of customary closing conditions for the sale of the Avoca business. Factors that will influence the impact on our business and operations include, without limitation, risks and uncertainties affecting Ashland that are described in its most recent Form 10-K (including Item 1A Risk Factors) filed with the SEC, which is available on Ashland’s website at http://investor.ashland.com or on the SEC’s website at http://www.sec.gov. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Unless legally required, Ashland undertakes no obligation to update any forward-looking statements made in this news release whether because of new information, future events or otherwise. Information on Ashland’s website is not incorporated into or a part of this news release.
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 3,200 passionate, tenacious solvers thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit
ashland.com
and
ashland.com/ESG
to learn more.
About Mane
Founded in 1871 by Victor Mane, MANE is one of the leading producers and suppliers of fragrances and flavours globally. Since inception, the company has been owned and managed by five successive generations of the Mane family.
MANE is a global group, operating 29 production facilities worldwide and more than 79 sites in more than 40 countries and employing over 8,000 collaborators. The first French company and the fifth largest fragrances and flavours producer in the world and are recognised as the fastest growing major company within the industry.
™ Trademark, Ashland or its subsidiaries, registered in various countries.
FOR FURTHER INFORMATION:
| Investor Relations Ashland: | Media Relations Ashland: |
| William C. Whitaker | Carolmarie C. Brown |
| +1 (614) 790-2095 | +1 (302) 995-3158 |
| [email protected] | [email protected] |
| Mane Contacts: | |
| Eliane Coloretti | Bertrand Boulin |
| + 33 4 93 09 70 00 | + 33 4 93 09 70 00 |
| [email protected] | [email protected] |
Attachment